Author:
Singh Vijay Kumar,Singh Veena,Tyagi Vishal
Publisher
Springer International Publishing
Reference144 articles.
1. Ades, S. (2009). Adjuvant chemotherapy for colon cancer in the elderly: Moving from evidence to practice. Oncology (Williston Park, NY), 23, 162–167.
2. Al-azzawi, S., & Masheta, D. (2019). Designing a drug delivery system for improved tumor treatment and targeting by functionalization of a cell-penetrating peptide. Journal of Pharmaceutical Investigation, 49, 643–654.
3. Amidon, S., Brown, J. E., & Dave, V. S. (2015). Colon-targeted oral drug delivery systems: Design trends and approaches. AAPS PharmSciTech, 16(4), 731–741. https://doi.org/10.1208/s12249-015-0350-9.
4. Amin, M., Mansourian, M., Koning, G. A., Badiee, A., Jaafari, M. R., & Ten Hagen, T. L. M. (2015). Development of a novel cyclic RGD peptide for multiple targeting approaches of liposomes to tumor region. Journal of Controlled Release, 220, 308–315.
5. Arshad, U., Sutton, P. A., Ashford, M. B., Treacher, K. E., Liptrott, N. J., Rannard, S. P., Goldring, C. E., & Owen, A. (2020). Critical considerations for targeting colorectal liver metastases with nanotechnology. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, 12(2), 1588. https://doi.org/10.1002/wnan.1588.